This document is a USPTO patent application (US20260078448A1) for methods of detecting and treating Sjögren's syndrome using salivary exosomes. The application, filed on September 7, 2023, by a team of inventors, describes novel diagnostic and therapeutic approaches for the autoimmune disease.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in diagnostics and therapeutics for Sjögren's syndrome, which may impact pharmaceutical and healthcare sectors. Compliance officers should note this as a potential area for future innovation and regulatory consideration.